» Articles » PMID: 15919751

Src Homology 3-domain Growth Factor Receptor-bound 2-like (endophilin) Interacting Protein 1, a Novel Neuronal Protein That Regulates Energy Balance

Overview
Journal Endocrinology
Specialty Endocrinology
Date 2005 May 28
PMID 15919751
Citations 23
Authors
Affiliations
Soon will be listed here.
Abstract

To identify genes involved in the central regulation of energy balance, we compared hypothalamic mRNA from lean and obese Psammomys obesus, a polygenic model of obesity, using differential display PCR. One mRNA transcript was observed to be elevated in obese, and obese diabetic, P. obesus compared with lean animals and was subsequently found to be increased 4-fold in the hypothalamus of lethal yellow agouti (A(y)/a) mice, a murine model of obesity and diabetes. Intracerebroventricular infusion of antisense oligonucleotide targeted to this transcript selectively suppressed its hypothalamic mRNA levels and resulted in loss of body weight in both P. obesus and Sprague Dawley rats. Reductions in body weight were mediated by profoundly reduced food intake without a concomitant reduction in metabolic rate. Yeast two-hybrid screening, and confirmation in mammalian cells by bioluminescence resonance energy transfer analysis, demonstrated that the protein it encodes interacts with endophilins, mediators of synaptic vesicle recycling and receptor endocytosis in the brain. We therefore named this transcript Src homology 3-domain growth factor receptor-bound 2-like (endophilin) interacting protein 1 (SGIP1). SGIP1 encodes a large proline-rich protein that is expressed predominantly in the brain and is highly conserved between species. Together these data suggest that SGIP1 is an important and novel member of the group of neuronal molecules required for the regulation of energy homeostasis.

Citing Articles

Analyses of GWAS signal using GRIN identify additional genes contributing to suicidal behavior.

Sullivan K, Lane M, Cashman M, Miller J, Pavicic M, Walker A Commun Biol. 2024; 7(1):1360.

PMID: 39433874 PMC: 11494055. DOI: 10.1038/s42003-024-06943-7.


A candidate loss-of-function variant in SGIP1 causes synaptic dysfunction and recessive parkinsonism.

Decet M, Scott P, Kuenen S, Meftah D, Swerts J, Calatayud C Cell Rep Med. 2024; 5(10):101749.

PMID: 39332416 PMC: 11513836. DOI: 10.1016/j.xcrm.2024.101749.


SGIP1 binding to the α-helical H9 domain of cannabinoid receptor 1 promotes axonal surface expression.

Fletcher-Jones A, Spackman E, Craig T, Nakamura Y, Wilkinson K, Henley J J Cell Sci. 2024; 137(11).

PMID: 38864427 PMC: 11213518. DOI: 10.1242/jcs.261551.


Forskolin-driven conversion of human somatic cells into induced neurons through regulation of the cAMP-CREB1-JNK signaling.

Wang G, Zhang D, Qin L, Liu Q, Tang W, Liu M Theranostics. 2024; 14(4):1701-1719.

PMID: 38389831 PMC: 10879881. DOI: 10.7150/thno.92700.


SGIP1 in axons prevents internalization of desensitized CB1R and modifies its function.

Durydivka O, Mackie K, Blahos J Front Neurosci. 2023; 17:1213094.

PMID: 37547151 PMC: 10397514. DOI: 10.3389/fnins.2023.1213094.